Clinical Trials Directory

Trials / Conditions / Lymphoma, Low-Grade

Lymphoma, Low-Grade

15 registered clinical trials studyying Lymphoma, Low-Grade.

StatusTrialSponsorPhase
WithdrawnOfatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas
NCT01263418
UNC Lineberger Comprehensive Cancer CenterPhase 2
CompletedTandem Auto-Allo Transplant for Lymphoma
NCT01181271
Massachusetts General HospitalPhase 2
CompletedPh I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
NCT00546793
Gilead SciencesPhase 1 / Phase 2
CompletedEfficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL
NCT00311129
Genzyme, a Sanofi CompanyPhase 2
TerminatedComparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
NCT00060671
CTI BioPharmaPhase 3
CompletedStudy for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma
NCT00220285
BayerPhase 2
CompletedZevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma
NCT00168727
BiogenPhase 4
CompletedStudy of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
NCT00143845
University of Michigan Rogel Cancer CenterPhase 2
CompletedDose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
NCT00060684
CTI BioPharmaPhase 1
TerminatedCampath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
NCT00038883
M.D. Anderson Cancer CenterN/A
UnknownIdiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
NCT00036426
FavrillePhase 2
CompletedPhase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
NCT00051025
Eisai Inc.Phase 2
TerminatedStudy of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood
NCT00143884
University of Michigan Rogel Cancer CenterPhase 2
CompletedTreatment of Localized Low Grade Lymphomas
NCT00536458
French Innovative Leukemia OrganisationPhase 3
UnknownFCM Versus R-FCM Followed by R-Maintenance or Observation Only
NCT00317096
Ludwig-Maximilians - University of MunichPhase 3